OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
April 03, 2021
Intensified and distributed manufacturing approaches create flexible, local capacity.
January 04, 2021
Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.
October 03, 2020
Excipients must be carefully chosen to ensure optimum protection for vaccines and live biotherapeutic products.
August 20, 2020
CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.
July 08, 2020
CordenPharma added a 3000-L solid-phase peptide synthesis vessel to its GMP API facility in Boulder, CO.
July 02, 2020
RNA is easier to manipulate than DNA but challenging to deliver to the right cells.
June 04, 2020
Agreements with the PolyPeptide Group and AGC Biologics will scale up production of the Novavax Matrix-M adjuvant.
May 02, 2020
Many antibody-drug conjugate therapies are in the pipeline; however, only a handful have been approved. What are the bottlenecks?
April 02, 2020
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
February 17, 2020
An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.